1. Home
  2. FPI vs PCRX Comparison

FPI vs PCRX Comparison

Compare FPI & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FPI
  • PCRX
  • Stock Information
  • Founded
  • FPI 2013
  • PCRX 2006
  • Country
  • FPI United States
  • PCRX United States
  • Employees
  • FPI N/A
  • PCRX N/A
  • Industry
  • FPI Real Estate Investment Trusts
  • PCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FPI Real Estate
  • PCRX Health Care
  • Exchange
  • FPI Nasdaq
  • PCRX Nasdaq
  • Market Cap
  • FPI 607.9M
  • PCRX 604.7M
  • IPO Year
  • FPI 2014
  • PCRX 2011
  • Fundamental
  • Price
  • FPI $11.41
  • PCRX $22.45
  • Analyst Decision
  • FPI
  • PCRX Buy
  • Analyst Count
  • FPI 0
  • PCRX 10
  • Target Price
  • FPI N/A
  • PCRX $27.60
  • AVG Volume (30 Days)
  • FPI 356.6K
  • PCRX 821.8K
  • Earning Date
  • FPI 02-26-2025
  • PCRX 02-27-2025
  • Dividend Yield
  • FPI 2.10%
  • PCRX N/A
  • EPS Growth
  • FPI N/A
  • PCRX N/A
  • EPS
  • FPI 0.32
  • PCRX N/A
  • Revenue
  • FPI $58,465,000.00
  • PCRX $694,957,000.00
  • Revenue This Year
  • FPI N/A
  • PCRX $4.83
  • Revenue Next Year
  • FPI N/A
  • PCRX $2.16
  • P/E Ratio
  • FPI $35.65
  • PCRX N/A
  • Revenue Growth
  • FPI 1.30
  • PCRX 4.40
  • 52 Week Low
  • FPI $9.70
  • PCRX $11.16
  • 52 Week High
  • FPI $12.85
  • PCRX $34.01
  • Technical
  • Relative Strength Index (RSI)
  • FPI 42.23
  • PCRX 68.72
  • Support Level
  • FPI $11.37
  • PCRX $18.18
  • Resistance Level
  • FPI $11.90
  • PCRX $22.36
  • Average True Range (ATR)
  • FPI 0.23
  • PCRX 1.17
  • MACD
  • FPI 0.01
  • PCRX 0.31
  • Stochastic Oscillator
  • FPI 24.18
  • PCRX 88.61

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, citrus, blueberries, and vegetables. The company generates its revenues through the rent it receives from its tenants.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

Share on Social Networks: